Latest Transformation News

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.

Aguia Resources has initiated a 25-hole diamond drilling campaign at its Santa Barbara Gold Project in Colombia, aiming to define a maiden JORC resource and explore extensive vein systems.

Riversgold Limited reports metallurgical tests confirming over 90% gold recovery at its Northern Zone project near Kalgoorlie, alongside promising drilling results that pave the way for a maiden resource estimate.

Mithril Silver and Gold Limited reports a significant maiden drill intercept at its Copalquin project in Mexico, revealing high-grade gold and silver mineralization at the Target 2 area. The company advances multiple exploration fronts, underscoring the district’s growing potential.

OFX Limited reported a resilient FY25 with steady revenue and strong cash flow, while advancing its New Client Platform and strategic market expansion despite economic headwinds.

Green360 Technologies has successfully produced high-quality metakaolin from its kaolin resources, surpassing industry benchmarks and initiating commercial-scale trials with PERMAcast to validate its low-carbon cement formulations.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.

Worley Limited has reaffirmed its FY25 financial outlook, targeting low double-digit EBITA growth and margins between 8-8.5%, supported by a robust $9.4 billion bookings pipeline and a strategic operational reorganisation.